Prednisolone disposition in steroid-dependent asthmatics. 1980

J Q Rose, and J A Nickelsen, and E Middleton, and A M Yurchak, and B H Park, and W J Jusko

A 40-mg intravenous dose of prednisolone was given as prednisolone phosphate to seven severe steroid-dependent asthmatics and to 13 healthy volunteers to determine if the large prednisone requirements of these patients were a function of the disease, cellular response, or rapid clearance of prednisolone. Plasma concentrations of prednisolone, prednisone, and cortisol were determined by high-performance liquid chromatography over an 8-hr test period. Circulating eosinophil concentrations were monitored concurrently. The apparent half-lifes of prednisolone in the asthmatics and normals were 3.33 +/- 0.71 and 3.25 +/- 0.58 hr (mean +/- SD). The apparent plasma clearances of prednisolone were 201 +/- 54 and 198 +/- 38 ml/min/1.73 m2 and the apparent volumes of distribution were 50.8 +/- 11.7 and 53.5 +/- 13.5 L/1.73 m2 for the asthmatic and normal groups, respectively. When the concentration-dependent binding of prednisolone to plasma protein was examined, no differences in the apparent clearances of unbound drug were found between the two groups. The eosinopenic response to prednisolone was similar in the steroid-dependent asthmatics and healthy normal volunteers. These studies indicate that binding, distribution, and clearance of prednisolone are not responsible for the large prednisone requirement of some steroid-dependent asthmatics. Differences in steroid-receptor sensitivity or in severity or pathophysiology of the disease state more likely account for the need for large prednisone dosages in these patients.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D011241 Prednisone A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. Dehydrocortisone,delta-Cortisone,Apo-Prednisone,Cortan,Cortancyl,Cutason,Dacortin,Decortin,Decortisyl,Deltasone,Encorton,Encortone,Enkortolon,Kortancyl,Liquid Pred,Meticorten,Orasone,Panafcort,Panasol,Predni Tablinen,Prednidib,Predniment,Prednison Acsis,Prednison Galen,Prednison Hexal,Pronisone,Rectodelt,Sone,Sterapred,Ultracorten,Winpred,Acsis, Prednison
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D004804 Eosinophils Granular leukocytes with a nucleus that usually has two lobes connected by a slender thread of chromatin, and cytoplasm containing coarse, round granules that are uniform in size and stainable by eosin. Eosinophil
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes

Related Publications

J Q Rose, and J A Nickelsen, and E Middleton, and A M Yurchak, and B H Park, and W J Jusko
July 2002, International archives of allergy and immunology,
J Q Rose, and J A Nickelsen, and E Middleton, and A M Yurchak, and B H Park, and W J Jusko
January 1976, Nigerian medical journal : journal of the Nigeria Medical Association,
J Q Rose, and J A Nickelsen, and E Middleton, and A M Yurchak, and B H Park, and W J Jusko
February 1986, Irish medical journal,
J Q Rose, and J A Nickelsen, and E Middleton, and A M Yurchak, and B H Park, and W J Jusko
January 1985, Allergologia et immunopathologia,
J Q Rose, and J A Nickelsen, and E Middleton, and A M Yurchak, and B H Park, and W J Jusko
September 1980, Clinical allergy,
J Q Rose, and J A Nickelsen, and E Middleton, and A M Yurchak, and B H Park, and W J Jusko
December 1995, Chest,
J Q Rose, and J A Nickelsen, and E Middleton, and A M Yurchak, and B H Park, and W J Jusko
November 1989, DICP : the annals of pharmacotherapy,
J Q Rose, and J A Nickelsen, and E Middleton, and A M Yurchak, and B H Park, and W J Jusko
November 1981, Journal of pharmaceutical sciences,
J Q Rose, and J A Nickelsen, and E Middleton, and A M Yurchak, and B H Park, and W J Jusko
April 1971, The Practitioner,
J Q Rose, and J A Nickelsen, and E Middleton, and A M Yurchak, and B H Park, and W J Jusko
June 1989, New Jersey medicine : the journal of the Medical Society of New Jersey,
Copied contents to your clipboard!